Listing & Compliance Notices

Global Technology Acquisition Corp. I received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“October 9, 2023, Global Technology Acquisition Corp. I, a Cayman Islands exempted company (the “Company” or “GTAC”), received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company was not in compliance with Listing Rule 5450(a)(2) (the “Minimum Public Holders Rule”), which requires the Company to maintain a minimum of 400 public holders for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no immedia”

EBET, Inc. received a nasdaq delisting notice notice regarding other.

“October 12, 2023, EBET, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that it would delist the Company’s shares of common stock from the Nasdaq Capital Market upon the opening of trading on October 13, 2023. The Company’s common stock will be traded on the OTC Pink Sheets while it pursues an uplisting to the OTCQB exchange. There can be no assurance that a market for the Company’s shares will develop on either the OTC Pink Sheets or OTCQB exchange, if the Company is able to uplist to such exchange.”

Evolution Metals & Technologies Corp. received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“October 9, 2023, Welsbach Technology Metals Acquisition Corp., (the “Company” or “WTMA”) received a letter (the “Notice”) from the Nasdaq Listing Qualifications department of Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with the requirements of Nasdaq Listing Rule 5450(a)(2) (the “Rule”) for continued listing on Nasdaq. Under the Rule, the Company is required to maintain at least 400 total holders (the “Total Holder Requirement”). The Notice indicates that the Company has 45 calendar days (the “Deadline”) to submit a plan (the “Compliance Plan”) to regain comp”

TG Venture Acquisition Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2), 5810(c)(2)(C), 5810(c)(2)(B)(i)).

“October 9, 2023, TG Venture Acquisition Corp. (“TGVC”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that, based on the number of beneficial holders and holders of record of TGVC’s Class A common stock (the “Total Holders”), TGVC no longer meets Listing Rule 5450(a)(2), which requires listed companies to maintain a minimum of 400 Total Holders. Nasdaq Listing Rule 5810(c)(2)(C) provides TGVC with a period of 45 calendar days, or until November 24, 2023 (the “Compliance Date”), to submit a plan to regain comp”

Achari Ventures Holdings Corp. I received a nasdaq delisting notice notice regarding shareholders (rules 5450(a)(2)).

“October 9, 2023, the Company received an additional letter from the Staff stating that on September 3, 2023, the Company reported less than the 400 total shareholders required under Nasdaq Listing Rule 5450(a)(2), and this matter serves as an additional basis for delisting the Company’s securities. The Company intends to request a hearing to stay the suspension of trading of the Company’s Securities, and the Company’s Securities will continue to trade on Nasdaq Global until the hearing process concludes and the Nasdaq hearings panel (the “ Panel ”) issues a written decision. There can be no as”

Achari Ventures Holdings Corp. I received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

“October 5, 2023, Achari Ventures Holdings Corp. I, a Delaware company (the “ Company ”) received a letter (the “ Letter ”) from the staff at The Nasdaq Stock Market LLC (the “ Staff ”) stating that the Company has not regained compliance with the Market Value of Listed Securities (“ MVLS ”) requirement because the Company’s MVLS was below the $50,000,000 minimum MVLS requirement for the proceeding 30 consecutive trading days for continued listing on The Nasdaq Global Market (“ Nasdaq Global ”) under Nasdaq Listing Rule 5450(b)(2)(A) (the “ MLVS Rule ”). As previously disclosed, the Company was”

Royalty Management Holding Corp received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“October 5, 2023, the Company received a letter (the “Delisting Notice”) from the Staff stating that as the Company had not regained compliance with the MVLS Rule, its securities would be delisted effective as of the opening of the market on October 16, 2023. The Delisting Notice provided that the Company may appeal the delisting determination to a Hearings Panel. While the board of directors of the Company has not yet requested an appeal, it anticipates that it will do so which would suspend the delisting until the Hearings Panel made a final determination.”

SHIFT TECHNOLOGIES, INC. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“October 10, 2023, the Company was notified by the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that it commenced proceedings to delist the common stock of the Company, par value $0.0001 (the “Common Stock”) pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, and has determined that the Common Stock will be delisted from the Nasdaq due to the Company’s filing of voluntary cases under Chapter 11 of the Bankruptcy Code. The Company does not intend to appeal the determination and, therefore, it is expected that its Common Stock will be delisted, wh”

Nxu, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 29, 2023, Staff notified the Company that it failed to comply with Nasdaq’s $2,500,000 minimum stockholders’ equity requirement for continued listing as set forth in Listing Rule 5550(b)(1) (the “Equity Rule”). The Company intends to address its noncompliance with the Equity Rule at the hearing before the Panel as well. There can be no assurance that the appeal will be successful, that the Panel will grant the Company’s request for continued listing or that the Company will evidence compliance within any extension period that may be granted by the Panel. SIGNATURE Pursuant to the requir”

Nxu, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(b)(1)).

“ion of the events that it believes will enable it to regain compliance. Additionally, as previously disclosed, on August 29, 2023, Staff notified the Company that it failed to comply with Nasdaq’s $2,500,000 minimum stockholders’ equity requirement for continued listing as set forth in Listing Rule 5550(b)(1) (the “Equity Rule”). The Company intends to address its noncompliance with the Equity Rule at the hearing before the Panel as well. There can be no assurance that the appeal will be successful, that the Panel will grant the Company’s request for continued listing or that the Company will”

Virpax Pharmaceuticals, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 10, 2023, the Company received written notification from Nasdaq granting the Company’s request for a 180-day extension to regain compliance with Nasdaq Listing Rule 5550(a)(2). Compliance may be achieved if at any time prior to April 8, 2024 the closing bid price of the Company’s common stock is at least $1.00 for a minimum of ten consecutive business days, Nasdaq will notify the Company that it has regained compliance with the Minimum Bid Price Requirement and the matter will be closed; however, Nasdaq has discretion to require the Company to maintain a bid price of $1.00 for a period”

DMK PHARMACEUTICALS Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“armaceuticals Corporation (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with the $1.00 minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on The Nasdaq Capital Market. Based on the closing bid price of the Company’s common stock for at least 30 consecutive business days before receipt of the Notice, the Company no longer meets the minimum bid price requirement of the Rule. This notice has”

Spectaire Holdings Inc. received a nasdaq noncompliance notice notice regarding shareholders (rules 5450(a)(2)).

“October 9, 2023, PCCT received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that PCCT is not in compliance with Listing Rule 5450(a)(2) of the Nasdaq Global Market in connection with its listing of PCCT’s Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), which requires PCCT to maintain a minimum of 400 total holders of its Class A Ordinary Shares for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effec”

Global System Dynamics, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“October 4, 2023, the Company received written notification (the “Notification”) from Nasdaq stating that the Company had not regained compliance with the Market Value Standard. Pursuant to the Notification, the Securities are subject to delisting from Nasdaq pending the Company’s opportunity to request a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company intends to diligently pursue an appeal of the Notification before the Panel and regain compliance with the Rule. Under Nasdaq rules, the delisting of the Securities will be stayed during the pendency of the appeal and during s”

Unique Fabricating, Inc. received a nyse_american extension granted notice regarding late filing (rules 134, 1101, 1007).

“October 3, 2023, the NYSE American granted an extension through March 31, 2024 for the Company to cure its filing deficiency. Pursuant to Section 1007 of the Company Guide, an issuer is required to submit an extension request when it is unable to cure the filing deficiency within the initial six-month period of the maximum 12-month cure period from when it became delinquent. A company’s common stock will continue to be listed and traded on the NYSE during the cure periods, subject to a company’s compliance with other continued listing requirements. The current noncompliance with the NYSE listi”

iSpecimen Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 9, 2023, iSpecimen Inc., a Delaware corporation (the “Company”) received a deficiency notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that its common stock, par value $0.0001 per share (the “Common Stock”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice from Nasdaq. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasd”

Veradigm Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“eport on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”) and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 (the “Q1 Form 10-Q) and June 30, 2023 (together with the Q1 Form 10-Q, the “Form 10-Qs”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Filing Rule”), which requires listed companies to timely file all periodic reports with the Securities and Exchange Commission (the “SEC”). As previously disclosed on September 18, 2023, the Company did not regain compliance within the expiration of the 180-day extension that was pr”

INSEEGO CORP. received a nasdaq extension granted notice regarding minimum bid price (rules 5555(a)(1)).

“October 9, 2023, Inseego Corp. (the “Company”) received a letter from the hearings panel of the Nasdaq Stock Market (“Nasdaq”) informing the Company that Nasdaq has granted the Company a temporary exception to regain compliance with Nasdaq Rule 5555(a)(1) (the “Bid Price Rule”). The Company has represented that it intends to effect a reverse stock split if necessary to regain compliance no later than March 1, 2024, and described the actions it intends to take to be able to meet that timeline. Accordingly, the Company has been granted an exception until March 15, 2024, to effect the reverse sto”

REGIS CORP received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“October 4, 2023, Regis Corporation (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing compliance standards set forth under Section 802.01C of the NYSE Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period (the “Share Price Deficiency”). As set forth in the Notice, as of October 3, 2023, the 30 trading-day average price of the Company’s common stock was $0.92. As req”

Forza X1, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 4, 2023, Forza X1, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (August 22, 2023 through October 3, 2023), the Company’s common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on The Nasdaq Capit”

Marpai, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 6, 2023, Marpai, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company did not satisfy the requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”) to maintain a minimum bid price of $1.00 per share. The Company became deficient with Rule 5550(a)(2) as of October 6, 2023 as the closing bid price of its Class A common stock was less than $1.00 per share for 30 consecutive business days prior to the date o”

HYCROFT MINING HOLDING CORP received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)).

“October 3, 2023, Hycroft Mining Holding Corporation (the “Company”) received formal notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a) as of October 2, 2023, the Company’s securities were subject to delisting unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which request will stay any further action by Nasdaq”

Datavault AI Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 5, 2023, WiSA Technologies, Inc., a Delaware corporation (the “Company”), received a written notification (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), because the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), was below $1.00 per share for the previous”

Ondas Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 3, 2023, Ondas Holdings Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until April 1, 2024”

Axcella Health Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(A)).

“October 3, 2023, we received written notice from the Staff of Nasdaq that we did not regain compliance with the MVPHS and MVLS listing rule requirements. We plan to submit our views with respect to these deficiencies to the Nasdaq’ Hearings Panel in writing no later than October 10, 2023. The Company was granted a hearing before the Panel, which is expected to take place on October 30, 2023. Such hearing will stay any further delisting action by the Staff at least pending the ultimate outcome of the hearing and the expiration of any extension that may be granted by the Panel. The Company’s com”

Nemaura Medical Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“al Market. Accordingly, the Company was granted a grace period that expired on October 2, 2023. In addition, on April 6, 2023, the Company received a written notice that the Company was not in compliance with the $1 bid price (“Bid Price”) requirement for continued listing set forth in Listing Rule 5550(a)(2) and was granted a grace period that expired on October 3, 2023. On October 3 and 4, 2023, respectively, the Company received written notices from the Nasdaq Staff indicating that the Company had not regained compliance with the MVLS and Bid Price requirements, and that the Company’s commo”

Nemaura Medical Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“October 3, 2023. On October 3 and 4, 2023, respectively, the Company received written notices from the Nasdaq Staff indicating that the Company had not regained compliance with the MVLS and Bid Price requirements, and that the Company’s common stock would be subject to delisting from The Nasdaq Capital Market unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”). Accordingly, the Company intends to timely request a hearing before the Panel. The hearing request will automatically stay any suspension or delisting action pending the hearing and the expiration o”

Greenwave Technology Solutions, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 3, 2023, Greenwave Technology Solutions, Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until November 13, 2023, to regain complia”

BOLLINGER INNOVATIONS, INC. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“October 3, 2023, the Company received an additional written notice from the Staff indicating that the Staff had concluded that the Company did not hold an annual meeting in the fiscal year ended September 30, 2023, that met the Nasdaq annual meeting standard, as set forth in Nasdaq Listing Rule 5620(a) (the “Annual Meeting Rule”). While the Company held an annual meeting on August 3, 2023 and the proposals that were approved at the meeting including the election of directors are, and remain, valid, the Staff determined that such meeting did not satisfy the Annual Meeting Rule since the Company”

BOLLINGER INNOVATIONS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 6, 2023, Mullen Automotive Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (the “Staff”) indicating that the Company did not meet the Staff’s September 5, 2023, deadline to regain compliance with Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) due to the Company’s failure to maintain a minimum bid price of $1.00 per share for a minimum of ten consecutive business days prior to the expiration of the previously granted Nasdaq grace period (pursuant to the Nasdaq Listing Rules, Nasdaq has the discretion to moni”

Firsthand Technology Value Fund, Inc. received a nasdaq deficiency notice notice regarding minimum bid price.

“October 6, 2023, Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund” or “Firsthand”), notified the Nasdaq Stock Market LLC (“Nasdaq”) of the Fund’s decision to voluntarily delist its common stock from the Nasdaq Global Market and its intent to file a Form 25 with the U.S. Securities and Exchange Commission (the “SEC”) on or about October 16, 2023. As a result, the Fund expects the delisting of its common stock to become effective on or about October 26, 2023. As previously noted in the Fund’s Current Report on Form 8-K filed with the SEC on May 3, 2023, and on the Fund’s Current R”

Big Digital Energy, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 4, 2023, Mawson Infrastructure Group Inc. (the “Company”) received written notice (“The Bid Price Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810-2(c)(3)(A), the Company has a period of 180 calendar days, or until April 1, 2024, to regain compliance with the Bid Price Rule. To regain compliance, the closing bid price of the”

Oncternal Therapeutics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 3, 2023, Nasdaq notified Oncternal that it has granted Oncternal an additional 180 calendar days, or to April 1, 2024, to regain compliance with the Minimum Bid Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). Oncternal intends to continue to actively monitor the closing bid price of its common stock and will evaluate available options to regain compliance with the Minimum Bid Requirement. Specifically, Oncternal has confirmed to Nasdaq that, if necessary, it will implement a reverse stock split of its outstanding common stock, to attempt to regain compliance. At Onct”

Ernexa Therapeutics Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(4)).

“October 3, 2023, Eterna Therapeutics Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Staff (“Staff”) of The Nasdaq Stock Market LLC (the “Nasdaq”) stating that, as a result of the previously disclosed resignations of Mr. Brant C. Binder and Dr. Richard W. Wagner from the Company’s board of directors and audit committee, the Company is no longer in compliance with Nasdaq Listing Rule 5605, which, in relevant part, requires the audit committee to consist of at least three members, each of whom must be an independent director under the Nasdaq Listing Rules”

EVI INDUSTRIES, INC. received a nyse_american compliance regained notice regarding late filing (rules 1007).

“October 5, 2023, the Company filed the Form 10-K with the SEC and, accordingly, has regained compliance with the NYSE American’s continued listing standards. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EVI INDUSTRIES, INC. Dated: October 5, 2023 By: /s/ Robert H. Lazar Robert H. Lazar Chief Financial Officer”

EVI INDUSTRIES, INC. received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

“September 29, 2023, EVI Industries, Inc. (the “Company”) received notice (the “Notice”) from NYSE Regulation that the Company was not in compliance with the timely filing criteria established in the NYSE American Company Guide as a result of the delayed filing of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the “Form 10-K”). In accordance with Section 1007 of the NYSE American Company Guide, the Company had an automatic six-month cure period to regain compliance with the NYSE American’s continued listing standards by filing the Form 10-K with the SEC. On Oc”

Eightco Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“September 29, 2023, Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with the minimum bid price requirement of $1.00 per share set forth in Nasdaq Rules for continued listing on Nasdaq. Based on the closing bid price of the Company’s listed securities for the 31 consecutive business days from August 16, 2023 to September 28, 2023, the Company no longer meets the minimum bid price requirement set forth in Listing Rule 5550(a)(2). The Notice is only a notification of def”

Molekule Group, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“October 4, 2023, the Company received written notice (the “Delisting Notice”) from the staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 11 Case and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq has determined that the Company's common stock, par value $0.01 per share (the “Common Stock”), will be delisted from The Nasdaq Stock Market. In the Delisting Notice, the staff of Nasdaq referenced the Chapter 11 Case and associated public interest concerns raised by them, concerns regarding the residual eq”

Movella Holdings Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 2, 2023, Movella Holdings Inc. (“the Company”) received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), as the minimum closing bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Global Market. The Company has 180 calendar days, or until April 1, 2024, to regain compliance with the minimum bid price requirement. To regain compl”

Equillium, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 3, 2023, in connection with the transfer of the listing of the Company’s common stock from the Nasdaq Global Market to the Nasdaq Capital Market, the Company was granted an additional 180-day grace period, or until April 1, 2024, to regain compliance with the Minimum Bid Price Requirement. The Company’s failure to regain compliance during this period could result in delisting. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements, including such actions as a reverse stock split.”

Aditxt, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5550(b)(1), 5550(a)(2), 5550(a)(4)).

“March 31, 2023, and as of March 31, 2023, the Company was no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a company to maintain a minimum of $2,500,000 in stockholders’ equity, or a market value of listed securities of at least $35 million, or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the three most recently completed fiscal years (the “Equity Rule”). The May Notification Letter further provided that the Company had 45 calendar days, or until July 7, 2023, to submit a plan to regain compliance and if th”

DATASEA INC. received a nasdaq compliance regained notice regarding market value (rules 5550(b)(1)).

“October 4, 2023, Nasdaq informed the Company that the Company has demonstrated compliance with the Equity Standard in Listing Rule 5550(b)(1) of The Nasdaq Stock Market, as required by the Panel’s decision dated August 11, 2023. Accordingly, the Panel has determined to continue the listing of the Company’s securities on Nasdaq. 1 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DATASEA INC. October 5, 2023 By: /s/ Zhixin Liu Name: Zhixin Liu Title: C”

RITE AID CORP received a nyse deficiency notice notice regarding minimum bid price (rules 802.01B, 802.01C).

“September 28, 2023, Rite Aid Corporation (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company is no longer in compliance with NYSE continued listing standards set forth in Section 802.01B (the “Minimum Market Capitalization Standard”) and Section 802.01C (the “Minimum Stock Price Standard”) of the NYSE’s Listed Company Manual due to the fact that (i) the Company’s average total market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, its stockholders’ equity was less than $50”

Zalatoris II Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“September 27, 2023, Zalatoris II Acquisition Corp., a Cayman Islands limited liability company (NASDAQ: ZLS) (the “Company”), received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not complied with the requirements of Nasdaq Listing Rule 5550(a)(3) (the “Rule”) for continued listing on Nasdaq. Under the Rule, the Company is required to maintain at least 300 public holders (the “Total Holder Requirement”). The Notice indicates that the Company has until November 13, 2023 to submit a plan (the “Complianc”

IMPEL PHARMACEUTICALS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“September 28, 2023, the Company received notice (the “Notice”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Select Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), th”

Cuentas Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“ued Listing Rule or Standard; Transfer of Listing. On October 3 2023, Cuentas Inc.(Nasdaq: CUEN) (“the “Company”) received a Staff Determination Letter from Nasdaq Regulation stating that due to the Company’s failure by October 2, 2023, to submit a plan to regain compliance with Nasdaq Listing Rule 5550(b)(1), the $2.5 million stockholders’ equity requirement, the Company would be subject to delisting unless it timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”). Accordingly, the Company intends to timely request a hearing before the Panel. The hearing request will stay any”

Ascent Solar Technologies, Inc. received a nasdaq noncompliance notice notice regarding shareholders (rules 5550(a)(4)).

“September 29, 2023, the Nasdaq staff notified the Company that the Company had regained compliance with the Minimum Bid Price Requirement based on the closing bid price of the Company’s common stock having been at $1.00 per share or greater for ten consecutive business days. The Staff’s notification indicated that this matter is now closed. The Company remains non-compliant with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in Listing Rule 5550(b) and the minimum 500,000 publicly held shares requirement under Listing Rule 5550(a)(4). These remaining ma”

Ascent Solar Technologies, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)).

“September 29, 2023, the Nasdaq staff notified the Company that the Company had regained compliance with the Minimum Bid Price Requirement based on the closing bid price of the Company’s common stock having been at $1.00 per share or greater for ten consecutive business days. The Staff’s notification indicated that this matter is now closed. The Company remains non-compliant with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in Listing Rule 5550(b) and the minimum 500,000 publicly held shares requirement under Listing Rule 5550(a)(4). These remaining ma”

Ascent Solar Technologies, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“March 23, 2023, the Company received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market indicating that the Company was not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq (the “Bid Price Requirement”). The notice indicated that the Company would be provided 180 calendar days in which to regain compliance with the Bid Price Requirement. On September 29, 2023, the Nasdaq staff notified the Company that the Company had regained compliance with the Minimum Bid Price Requireme”

Green Giant Inc. received a nasdaq deficiency notice notice regarding other.

“October 2, 2023, Green Giant Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the Nasdaq Listing Rules (the “Rules”) as a result of not having held an annual meeting of stockholders within 12 months of the end of the Company’s fiscal year on September 30, 2022. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The”